{"AllianceGenome": "26361", "HGNC": "26361", "MIM": "611642", "_id": "220296", "_version": 1, "accession": {"genomic": ["AP003501.2", "CH471065.1", "CP068267.2", "NC_000011.10", "NC_060935.1", "NG_029603.1"], "protein": ["AAI04832.1", "AAI13563.1", "AAQ93018.1", "BAC05297.1", "BAC85486.1", "CAD39081.1", "EAW67614.1", "EAW67615.1", "EAW67616.1", "NP_001397972.1", "NP_689935.2", "Q14CZ8.1", "XP_005271506.1", "XP_054224010.1"], "rna": ["AK098396.1", "AK122595.1", "AL834419.1", "AY047587.1", "BC037810.1", "BC104831.1", "BC113562.1", "DA239226.1", "NM_001411043.1", "NM_152722.5", "XM_005271449.3", "XM_054368035.1"], "translation": [{"protein": "BAC85486.1", "rna": "AK122595.1"}, {"protein": "AAQ93018.1", "rna": "AY047587.1"}, {"protein": "CAD39081.1", "rna": "AL834419.1"}, {"protein": "AAI13563.1", "rna": "BC113562.1"}, {"protein": "NP_689935.2", "rna": "NM_152722.5"}, {"protein": "AAI04832.1", "rna": "BC104831.1"}, {"protein": "XP_054224010.1", "rna": "XM_054368035.1"}, {"protein": "BAC05297.1", "rna": "AK098396.1"}, {"protein": "XP_005271506.1", "rna": "XM_005271449.3"}, {"protein": "NP_001397972.1", "rna": "NM_001411043.1"}]}, "alias": ["GlialCAM", "HEPN1", "MLC2A", "MLC2B"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "definitive", "classification_date": "2023-01-12T07:00:00.000Z", "disease_label": "megalencephalic leukoencephalopathy with subcortical cysts 2A", "gcep": "Intellectual Disability and Autism Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0013490", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_7917eeb8-f47a-4828-80ce-ba18f697c6a0-2023-01-12T070000.000Z", "sop": "SOP9"}, {"classification": "definitive", "classification_date": "2023-01-12T19:00:00.000Z", "disease_label": "megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without intellectual disability", "gcep": "Intellectual Disability and Autism Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0013491", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_3da28582-9929-4fcd-8c77-13dc1705b168-2023-01-12T190000.000Z", "sop": "SOP9"}]}, "ensembl": {"gene": "ENSG00000165478", "protein": ["ENSP00000298251", "ENSP00000515485"], "transcript": ["ENST00000298251", "ENST00000526273", "ENST00000528971", "ENST00000703807"], "translation": [{"protein": "ENSP00000515485", "rna": "ENST00000703807"}, {"protein": "ENSP00000298251", "rna": "ENST00000298251"}], "type_of_gene": "protein_coding"}, "entrezgene": "220296", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 11.532147727, "exp_mis": 133.140967637, "exp_syn": 61.8384819501, "lof_z": 2.78051571103957, "mis_z": 1.36244795751444, "mu_lof": 9.46450078655e-07, "mu_mis": 1.79920566046e-05, "mu_syn": 8.77295756255e-06, "n_lof": 2.0, "n_mis": 101.0, "n_syn": 61.0, "p_li": 0.630644860946896, "p_null": 0.00148990082435081, "p_rec": 0.367865238228753, "syn_z": 0.0661017101685521}, "bp": 1251, "cds_end": 124805902, "cds_start": 124791033, "n_exons": 7, "nonpsych": {"exp_lof": 10.3131400503, "exp_mis": 120.380860627, "exp_syn": 55.8452333901, "lof_z": 2.54226968343916, "mis_z": 1.53454957784154, "mu_lof": 9.46450078655e-07, "mu_mis": 1.79920566046e-05, "mu_syn": 8.77295756255e-06, "n_lof": 2.0, "n_mis": 87.0, "n_syn": 59.0, "p_li": 0.552559093412665, "p_null": 0.00347275994529505, "p_rec": 0.44396814664204, "syn_z": -0.265789722182815}, "nontcga": {"exp_lof": 10.5974343534, "exp_mis": 122.477557143, "exp_syn": 56.879270244, "lof_z": 2.60525203623599, "mis_z": 1.50707656259852, "mu_lof": 9.46450078655e-07, "mu_mis": 1.79920566046e-05, "mu_syn": 8.77295756255e-06, "n_lof": 2.0, "n_mis": 89.0, "n_syn": 59.0, "p_li": 0.555747861449355, "p_null": 0.00278019478446987, "p_rec": 0.441471943766176, "syn_z": -0.178045362824379}, "transcript": "ENST00000298251.4"}, "exons": [{"cdsend": 124936006, "cdsstart": 124921137, "chr": "11", "position": [[124919204, 124921440], [124922387, 124922458], [124922744, 124922818], [124923339, 124923433], [124923728, 124924010], [124924727, 124925069], [124935921, 124936047]], "strand": -1, "transcript": "NM_152722", "txend": 124936047, "txstart": 124919204}], "exons_hg19": [{"cdsend": 124805902, "cdsstart": 124791033, "chr": "11", "position": [[124789100, 124791336], [124792283, 124792354], [124792640, 124792714], [124793235, 124793329], [124793624, 124793906], [124794623, 124794965], [124805817, 124805943]], "strand": -1, "transcript": "NM_152722", "txend": 124805943, "txstart": 124789100}], "generif": [{"pubmed": 15885354, "text": "encodes an Ig-like transmembrane glycoprotein and is involved in cell adhesion and growth control"}, {"pubmed": 15917256, "text": "the cytoplasmic domain of hepaCAM is essential to its function on cell-matrix interaction and cell motility"}, {"pubmed": 18082421, "text": "study examined the glycosylation of the GlialCAM (hepaCAM) extracellular domain expressed in HEK and CHO cells"}, {"pubmed": 18293412, "text": "GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous system."}, {"pubmed": 18845560, "text": "the expression of hepaCAM in MCF7 cells not only inhibits cell growth but also induces cellular senescence through the p53/21 pathway"}, {"pubmed": 19059381, "text": "hepaCAM is partially localized in the lipid rafts/caveolae and interacts with Cav-1 through its first immunoglobulin domain."}, {"pubmed": 19142852, "text": "The data suggest that an intact hepaCAM protein is critical for establishing a stable physical association with the actin cytoskeleton; and such association is important for modulating hepaCAM-mediated cell adhesion and motility."}, {"pubmed": 19507233, "text": "high expression of hepaCAM significantly accelerated cell adhesion but inhibited cell proliferation and migration; cell differentiation was noticeably less apparent in cells expressing low-level hepaCAM"}, {"pubmed": 20205955, "text": "HepaCAM is involved in cell adhesion and growth control, and its expression is frequently silenced in TCCB. The extracellular domain of hepaCAM is essential to its physiological and biological functions."}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20514407, "text": "The truncation mutant of hepaCAM failed to promote cell-ECM adhesion and migration, and lost the inhibitory effects on cell growth, suggesting a regulatory role of the cleavage in hepaCAM functions."}, {"pubmed": 20593288, "text": "There is a close relationship between hepaCAM and VEGF in urothelial carcinoma"}, {"pubmed": 20628239, "text": "Downregulation of hepaCAM expression plays an important role in the tumorigenesis and development of bladder cancer"}, {"pubmed": 21419380, "text": "Dominant HEPACAM mutations can cause either macrocephaly and mental retardation with or without autism or benign familial macrocephaly."}, {"pubmed": 21618595, "text": "Research implies that the decrease in c-Myc protein expression, resulting from ectopic expression of hepaCAM, may contribute to the inhibition of proliferation in these cells."}, {"pubmed": 21624973, "text": "study presents more detailed characterization of the effect of mutations found in MLC1 and GLIALCAM megalencephalic leukoencephalopathy with subcortical cysts"}, {"pubmed": 22906662, "text": "Results suggest an important connection between HEPACAM and interferon-gamma, which may inhibit BIU-87 proliferation through HEPACAM re-expression and p21(WAF1) up-regulation to arrest cells at the G(0)/G(1) phase"}, {"pubmed": 23793458, "text": "results indicate GlialCAM is necessary for MLC1 protein expression, and its reduction affects the activity of volume-regulated anion currents (VRAC) which may cause astrocyte vacuolation; work extends the role of GlialCAM as a chaperone of MLC1 needed for proper VRAC activation"}, {"pubmed": 24202401, "text": "analysis of mutations in GLIALCAM in patients with megalencephalic leukoencephalopathy with subcortical cysts [case report]"}, {"pubmed": 24324362, "text": "Re-activation of hepaCAM gene by 5-aza-CdR can inhibit growth of cancer cells and arrest cells at G0/G1 phase"}, {"pubmed": 24515280, "text": "HepaCAM may prevent the translocation of PKCepsilon from cytosolic to particulate fractions, resulting in the inhibition of 786-0 cell proliferation."}, {"pubmed": 24580998, "text": "No clear association between GLIALCAM mutations and an autism-epilepsy phenotype."}, {"pubmed": 24645843, "text": "High expression of hepaCAM is associated with renal carcinoma."}, {"pubmed": 24811146, "text": "results suggested that HepaCAM acted as a tumor suppressor in prostate cancer"}, {"pubmed": 24824219, "text": "we demonstrate an evolutionary conserved role for MLC1 in regulating glial surface levels of GLIALCAM, and this interrelationship explains why patients with mutations in either gene (MLC1 or GLIALCAM) share the same clinical phenotype."}, {"pubmed": 25044933, "text": "Results allow classifying the effect of HEPACAM gene mutations in different subtypes and authors indicate different cellular mechanisms that lead to megalencephalic leukoencephalopathy pathogenesis."}, {"pubmed": 25185546, "text": "GlialCAM is able to interact with all CLC channels tested in this study, targeting them to cell junctions and activating them by stabilizing the open configuration of the common gate"}, {"pubmed": 26033718, "text": "The extracellular domain of GlialCAM is necessary for cell junction targeting and for mediating interactions with itself or with MLC1 and ClC-2."}, {"pubmed": 26392113, "text": "The suppressive roles of HEPACAM in NSCLC."}, {"pubmed": 26677113, "text": "Due to the ability to reactivate expression of hepaCAM and inhibit growth of bladder cancer cells, AZAC may represent an effective treatment for bladder cancer."}, {"pubmed": 26873485, "text": "HepaCAM proteins were significantly decreased in bladder carcinoma. Low hepaCAM was not statistically associated with clinicopathological characteristics of the patients. HepaCAM overexpression activated caspase 3/8/9, downregulated poly-ADP ribose polymerase and p-SMAD2/3, and decreased apoptosis."}, {"pubmed": 27322623, "text": "Out of 20 patients, macrocephaly, classic MRI features, motor development delay and cognitive impairment were detected in 20(100%), 20(100%), 17(85%) and 4(20%) patients, respectively. 20(100%) were clinically diagnosed with MLC. 19(95%) were genetically diagnosed with 10 novel mutations in MLC1, MLC1 and GlialCAM mutations were identified in 15 and 4 patients, respectively"}, {"pubmed": 27389245, "text": "In a group of Egyptian patients with megalencephalic leukoencephalopathy, novel mutations were identified in HEPACAM."}, {"pubmed": 27819278, "text": "hepaCAM associates with connexin 43, a main component of gap junctions, and enhances connexin 43 localization to the plasma membrane at cellular junctions."}, {"pubmed": 28093267, "text": "DNMT1 up-regulation induced by IL-6/STAT3 signaling was indispensable for IL-6-mediated hepaCAM loss in renal cell carcinoma (RCC) cell lines ACHN and 769-P, while DNMT3b up-regulation was crucial for hepaCAM loss in A498."}, {"pubmed": 28229220, "text": "HepaCAM depletion was discovered in bladder cancer tissues compared with adjacent normal tissues, and the decreased level was associated with the degradation of FoxO3."}, {"pubmed": 28244854, "text": "this study revealed that hepaCAM was downregulated in CRC tissues and cell lines. Overexpression of hepaCAM inhibited CRC cell proliferation, migration, and invasion in vitro. Furthermore, the tumorigenesis assay showed that increased expression of hepaCAM suppressed CRC tumor growth and metastasis in vivo."}, {"pubmed": 29658567, "text": "On the whole, this study indicates that HepaCAM potentially represents a therapeutic target and PF3084014 may prove to a promising agent for use in the treatment of refractory prostate cancer."}, {"pubmed": 30664187, "text": "The results suggest that HepaCAM and its cytoplasmic domain suppress the nuclear translocation of AR via Ran in prostate cancer (PCa). The cytoplasmic domain of HepaCAM may serve as a novel target for therapy in PCa."}, {"pubmed": 31372844, "text": "Six patients were clinically diagnosed with MLC. Of the six patients, five (Pt1-Pt5) presented with a heterozygous mutation in GLIALCAM (c.274C>T(p.Arg92Trp) or c.275G>C(p.Arg92Pro)) and were diagnosed with MLC2B; the remaining patient (Pt6) with two compound heterozygous mutations in GLIALCAM (c.203A>T (p.Lys68Met) and c.395C>A (p.Thr132Asn)) was diagnosed with MLC2A. The mutation c.275C>G (p.Arg92Pro) has not been repor"}, {"pubmed": 31960914, "text": "Structural basis for the dominant or recessive character of GLIALCAM mutations found in leukodystrophies."}, {"pubmed": 32335882, "text": "The heterozygous variant of the HEPACAM gene probably underlies the megalencephalic leukoencephalopathy with subcortical cyst in this child"}, {"pubmed": 33024272, "text": "Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM."}, {"pubmed": 34592353, "text": "Panobinostat reverses HepaCAM gene expression and suppresses proliferation by increasing histone acetylation in prostate cancer."}], "genomic_pos": {"chr": "11", "end": 124936412, "ensemblgene": "ENSG00000165478", "start": 124919205, "strand": -1}, "genomic_pos_hg19": {"chr": "11", "end": 124806308, "start": 124789089, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0007155", "qualifier": "involved_in", "term": "cell adhesion"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008104", "qualifier": "involved_in", "term": "protein localization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051726", "qualifier": "involved_in", "term": "regulation of cell cycle"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005911", "qualifier": "is_active_in", "term": "cell-cell junction"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005911", "pubmed": 21419380, "qualifier": "located_in", "term": "cell-cell junction"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0016020", "qualifier": "located_in", "term": "membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030424", "pubmed": 21419380, "qualifier": "located_in", "term": "axon"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0097450", "pubmed": 22405205, "qualifier": "located_in", "term": "astrocyte end-foot"}]}, "homologene": {"genes": [[7955, 100333891], [8364, 100493229], [9031, 428234], [9544, 716321], [9598, 466840], [9606, 220296], [9615, 489305], [9913, 521015], [10090, 72927], [10116, 300517]], "id": 17652}, "interpro": [{"desc": "Immunoglobulin subtype 2", "id": "IPR003598", "short_desc": "Ig_sub2"}, {"desc": "Immunoglobulin subtype", "id": "IPR003599", "short_desc": "Ig_sub"}, {"desc": "Immunoglobulin-like domain", "id": "IPR007110", "short_desc": "Ig-like_dom"}, {"desc": "Immunoglobulin V-set domain", "id": "IPR013106", "short_desc": "Ig_V-set"}, {"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Immunoglobulin-like domain superfamily", "id": "IPR036179", "short_desc": "Ig-like_dom_sf"}], "ipi": ["IPI00167215", "IPI00446859"], "map_location": "11q24.2", "name": "hepatic and glial cell adhesion molecule", "other_names": ["Putative cancer susceptibility gene HEPN1 protein", "hepatic and glial cell adhesion molecule", "hepatocyte cell adhesion molecule", "protein hepaCAM"], "pantherdb": {"HGNC": "26361", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1920177", "ortholog_type": "LDO", "panther_family": "PTHR12080", "taxid": 10090, "uniprot_kb": "Q640R3"}, {"Ensembl": "ENSRNOG00000009219", "ortholog_type": "LDO", "panther_family": "PTHR12080", "taxid": 10116, "uniprot_kb": "D3ZEI4"}, {"ZFIN": "ZDB-GENE-131121-449", "ortholog_type": "O", "panther_family": "PTHR12080", "taxid": 7955, "uniprot_kb": "A0A0R4IZN2"}, {"ZFIN": "ZDB-GENE-090429-4", "ortholog_type": "O", "panther_family": "PTHR12080", "taxid": 7955, "uniprot_kb": "A0A0R4IST1"}, {"Ensembl": "ENSDARG00000103603", "ortholog_type": "O", "panther_family": "PTHR12080", "taxid": 7955, "uniprot_kb": "A0A0G2KMX8"}, {"Ensembl": "ENSDARG00000112032", "ortholog_type": "O", "panther_family": "PTHR12080", "taxid": 7955, "uniprot_kb": "A0A2R8QAU8"}, {"ZFIN": "ZDB-GENE-050522-198", "ortholog_type": "LDO", "panther_family": "PTHR12080", "taxid": 7955, "uniprot_kb": "F8W2R4"}], "uniprot_kb": "Q14CZ8"}, "pdb": "7UQC", "pfam": ["PF07686", "PF13927"], "pharmgkb": "PA162390830", "pharos": {"target_id": 10006, "tdl": "Tbio"}, "prosite": "PS50835", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": {"id": "GNF271564", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF279080", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF335706", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF105684", "relationship": "is"}, {"id": "GNF145330", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1", "NG_029603.1"], "protein": ["NP_001397972.1", "NP_689935.2", "XP_005271506.1", "XP_054224010.1"], "rna": ["NM_001411043.1", "NM_152722.5", "XM_005271449.3", "XM_054368035.1"], "translation": [{"protein": "XP_005271506.1", "rna": "XM_005271449.3"}, {"protein": "NP_001397972.1", "rna": "NM_001411043.1"}, {"protein": "XP_054224010.1", "rna": "XM_054368035.1"}, {"protein": "NP_689935.2", "rna": "NM_152722.5"}]}, "reporter": {"GNF1H": "gnf1h08718_at", "HG-U133_Plus_2": "238003_at", "HG-U95B": "59326_at", "HTA-2_0": "TC11002415.hg.1", "HuEx-1_0": "3396249", "HuGene-1_1": "7952475", "HuGene-2_1": "16745752"}, "summary": "The protein encoded by this gene is a single-pass type I membrane protein that localizes to the cytoplasmic side of the cell membrane. The encoded protein acts as a homodimer and is involved in cell motility and cell-matrix interactions. The expression of this gene is downregulated or undetectable in many cancer cell lines, so this may be a tumor suppressor gene. [provided by RefSeq, Jul 2011].", "symbol": "HEPACAM", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1968841"}, "unigene": "Hs.745294", "uniprot": {"Swiss-Prot": "Q14CZ8", "TrEMBL": "A0A994J4I1"}}